About CR
Contact Us
Subscribe
Send Letter to Editor
HOME | CURRENT ISSUE | ARCHIVES | SUPPLEMENTS | CME | MAINTAINING CERTIFICATION | RESOURCES

February 2006




Diabetes • CAD/Angina
The Prognostic Role of Metabolic Syndrome After Myocardial Infarction
  by Giacomo Levantesi, MD1 • Alejandro Macchia, MD1 • RosaMaria Marfisi, MS1 • Maria G. Franzosi, MSc2 • Aldo P. Maggioni, MD3 Gian L. Nicolosi, MD4 • Carlo Schweiger, MD5 • Luigi Tavazzi, MD1 • Gianni Tognoni, MD1 • Franco Valagussa, MD6 Roberto Marchioli, MD,1 on behalf of GISSI-Prevenzione Investigators
  The 1Consorzio Mario Negri Sud, Santa Maria Imbaro, Chieti; 2Istituto Mario Negri, Milano; 3Centro Studi ANMCO, Firenze; 4Ospedale S. Maria degli Angeli, Pordenone; 5Ospedale Civile, Presidio di Riabilitazione, Passirana di Rho, Milano; 6Ospedale San Gerardo, Monza, Italy
  Commentary
A Weighty Problem
  by Alan G. Wasserman, MD
Hypertension
White-coat Hypertension And Progression to Home Hypertension
  by Takashi Ugajin, MS1 • Atsushi Hozawa, MD, PhD2 • Takayoshi Ohkubo, MD, PhD3,4 • Kei Asayama, MD1,4 • Masahiro Kikuya, MD, PhD3 Taku Obara, MS1 • Hirohito Metoki, MD1,4 • Haruhisa Hoshi, MD, PhD5 • Junichiro Hashimoto, MD, PhD3,4 • Kazuhito Totsune, MD, PhD1,4 Hiroshi Satoh, MD, PhD4,6 • Ichiro Tsuji, MD, PhD2 • Yutaka Imai, MD, PhD1,4
  The Departments of 1Clinical Pharmacology and Therapeutics, 2Public Health, and 3Planning for Drug Development and Clinical Evaluation Health, Tohoku University Graduate School of Medicine and Pharmaceutical Science; the 4Tohoku University 21st Century COE Program "Comprehensive Research and Education Center for Planning of Drug Development and Clinical Evaluation," Sendai; 5Ohasama Hospital, Iwate; and the 6Department of Environmental Health Science, Tohoku University Graduate school of Medicine and Pharmaceutical Science, Japan
  Case Report
Is It White-coat Hypertension?
  Commentary
White-coat Hypertension and the Development of Sustained Hypertension
  by Peter Buttrick, MD
Lipid Disorders
Lipid-lowering Therapy and Atherosclerotic Aortic Plaques
  by Yukihiko Momiyama, MD • Atsushi Yonemura, MD • Fumitaka Ohsuzu, MD
  National Defense Medical College, Saitama, Japan
  Case Report
Lipid-lowering Therapy for Aortic Plaques
  Commentary
Thoracic and Abdominal Aorticatherosclerosis
  by Roger S. Blumenthal, MD • Christine Tompkins, MD
Stroke
Aspirin and Clopidogrel After Recent Ischemic Stroke or Transient Ischemic Attack
  by Hans-Christoph Diener, MD
  University of Essen, Germany
  Commentary
The Match Trial: Disappointments and Surprises
  by Douglas Dulli, MD
Arrhythmias and Conduction Disturbances
Antiplatelet and Anticoagulant Therapy in Patients With Atrial Fibrillation
  by Francisco Perez-Gomez, MD • Cristina Fernαndez, MD
  Hospital Clinico San Carlos, Madrid, Spain
  Commentary
Combination Antithrombotic and Antiplatelet Therapy for Preventing Thromboembolic Complications in Patients With Atrial Fibrillation
  by Frank Mazzola, MD

Departments

  Editor's Page
Statins and Antiplatelet Agents
  by Peter F. Cohn, MD
  New Feature!
Maintaining Certification in Cardiology
  Preventive Cardiology in Special Patient Populations
How to Improve on Good News: Take Charge and Stay Alive for Yourself and Your Grandchildren
  by B. Waine Kong, PhD, JD, Chief Executive Officer, Association of Black Cardiologists, Inc.
News Beat

Search
   
Resources
Media Kit
Author Guidelines
Editorial Advisory Board
Reprints

Advertisement
Current Issue | Archives | Supplements | CME | Maintaining Certification | Resources
About CR | Contact Us | Subscribe | Send Letter to Editor
Media Kit | Author Guidelines | Editorial Advisory Board | Reprints
Other Healthcare Publications
The American Journal of Managed Care |  Cardiology Review |  Family Practice Recertification |  Internal Medicine World Report |  Pharmacy Times
Physician's Money Digest |  Resident & Staff |  Surgical Rounds